Blog
1 Cryptocurrency to Buy Before It Soars Over 1,300%, According to an Expert Analyst
After surging to new all-time highs in 2025, the cryptocurrency market has cooled significantly in 2026. The CoinMarketCap 20 Index is down more than 30% since it was established as a way to track
3 Less-Obvious Benefits of Retiring Late
For many people, retiring early is the ultimate dream. You can ditch the daily alarm clock, reclaim your time, and do all of the things you were too busy for while you were working.
But while
This $9 Million Solar Bet Lands Amid an 82% Stock Surge and $3 Billion Revenue Year
PlusTick Management opened a new position in Sunrun (NASDAQ:RUN) during the fourth quarter, acquiring 500,000 shares worth $9.20 million, according to a February 17, 2026, SEC filing.
According to a
Century Aluminum CEO Sells 150000 Shares as Aluminum Prices Soar
Jesse Gary, President and CEO of Century Aluminum Company (NASDAQ:CENX), reported the sale of 150,000 shares for a transaction value of ~$8.32 million on March 16, 2026, according to a SEC Form 4
Prediction: 2 Things That Will Happen to Alibaba in 2026
Alibaba Group (NYSE: BABA) has spent the past few years navigating regulatory pressure, intense competition, and shifting investor sentiment. But as the company enters 2026, the picture is becoming
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset
DAFNA Capital Management reported selling 222,847 shares of Syndax Pharmaceuticals (NASDAQ:SNDX) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.89 million based on
Is the Stock Market Sending a Warning Signal About Artificial Intelligence (AI) Stocks?
You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors
Ralliant Director Purchases 2350 Shares as Institutional Investors Push for Stock Buyback
Kate Mitchell, Director of Ralliant (NYSE:RAL), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026.
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February
Vita Coco CFO Sells 4000 Shares as Stock Sets to Join S&P SmallCap 600
Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), disclosed the sale of 4,000 shares of common stock on March 17, 2026 and March 18, 2026, as detailed in the SEC
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash
DAFNA Capital Management reported a buy of 720,000 shares of Biohaven (NYSE:BHVN) in a February 17, 2026, SEC filing, with the estimated transaction value at $8.92 million based on quarterly average
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
RTW Investments initiated a new stake in Apellis Pharmaceuticals (NASDAQ:APLS), acquiring 7,666,764 shares in the fourth quarter, according to a February 17, 2026, SEC filing.
An SEC filing dated
What Happens to Your Investments If the Stock Market Crashes?
More than half of U.S. investors feel pessimistic about the market's future, according to the most recent weekly survey from the American Association of Individual Investors, published on March 18
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
RTW Investments disclosed a significant buy of Cogent Biosciences (NASDAQ:COGT) in its February 17, 2026, SEC filing, adding 4,124,755 shares in a trade estimated at $115.95 million based on
Why Scholastic Stock Climbed This Week
Shares of Scholastic (NASDAQ: SCHL) rose this past week after the children's education and media leader's quarterly results earned higher marks than investors expected.
According to data from S&P
Why This $18 Million Sale Might Signal a Shift as a China Tech Bet Falls 34%
RWC Asset Advisors (US) LLC disclosed a sale of 834,689 shares of Kanzhun Limited (NASDAQ:BZ) in its February 17, 2026, SEC filing, an estimated $18.03 million trade based on quarterly average
Should Tesla Be Worried About Rivian?
For years, Tesla (NASDAQ: TSLA) has had much of the U.S. EV market to itself. There's a reason why Tesla's market cap is well above $1 trillion, while most other EV stocks are valued at less than
Is Apple Stock Going to $500? Here's What Has to Happen.
Apple's (NASDAQ: AAPL) past is defined by its winning performance. Shares have skyrocketed a jaw-dropping 953%, including dividends, in the last decade (as of March 17). This is impressive given the
Is Micron the Next Nvidia?
Micron (NASDAQ: MU) reported fantastic quarterly financial results, yet the stock is still falling.
*Stock prices used were the afternoon prices of March 19, 2026. The video was published on March
Reddit Stock is Crashing: Is This a Generational Buying Opportunity?
Reddit (NYSE: RDDT) is one of the fastest-growing social media companies in the world.
*Stock prices used were the afternoon prices of March 19, 2026. The video was published on March 21, 2026.
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
On February 17, 2026, FCPM III Services B.V. disclosed a buy of 1,489,096 RAPT Therapeutics (NASDAQ:RAPT) shares, an estimated $46.24 million trade based on quarterly average pricing.
According to
Why Is SoFi Stock Crashing, and Should You Buy the Dip?
For several months, I had been warning investors that SoFi (NASDAQ: SOFI) stock was too expensive. Since my warnings, the stock has crashed to lower levels.
*Stock prices used were the afternoon
Is This Stock a Buy on the Dip?
After becoming the first healthcare stock to hit a $1 trillion market valuation in late 2025, Eli Lilly (NYSE: LLY) hasn't performed well since, with its shares down about 19% from their 52-week
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
Kynam Capital Management disclosed in a February 17, 2026, SEC filing that it sold 1,720,949 shares of Cogent Biosciences (NASDAQ:COGT), an estimated $48.38 million trade based on quarterly average
Bristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?
Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
On March 2, 2026, Jennifer Dawn Whalen, SVP, CFO of Bristow


